Genomma Lab announces management changes
Genomma Lab anuncia cambios de directivos
Intel ID : 231910
| Synopsis |
|
Genomma Lab, a pharmaceutical laboratory headquartered in Mexico, appointed Antonio Zamora Galland as its new Executive Vice-President, as published by newspaper El Economista on 2 December 2015. Galland will replace Oscar Villalobos Torres, who will leave on 15 December 2015. Antonio Zamora Galland takes office and takes on the global responsibility of the Financial, Information Technology and Investors Relations operations.
(content in spanish)
Genomma Lab, laboratorio farmacéutico con sede en México, ha designado a Antonio Zamora Galland como nuevo vicepresidente ejecutivo, según ha informado El Economista el 2 de diciembre de 2015. Galland reemplazará en su cargo a Oscar Villalobos Torres, quien deja el cargo a partir del 15 de diciembre. Con este cargo, el nuevo directivo asume la responsabilidad global de las operaciones de Finanzas, Tecnologías de Información y Relación con Inversionistas. |
|
||||
| Intel ID | 231910 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
|
Financial Data - Genomma Lab
(31 Dec 2017) |
Revenue: EUR 512,23m Exchange Rate:
|
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.